| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/16/2002 | CN1331132A Polypeptide-human calbindin 15 and polynucleotide for coding it |
| 01/16/2002 | CN1331131A Polypeptide-human Mch2 protein 11.55 and polynucleotide for coding it |
| 01/16/2002 | CN1331130A Polypeptide-human latexin protein 21 and polynucleotide for coding it |
| 01/16/2002 | CN1331129A Polypeptide-human transport protein 20.24 and polynucleotide for coding it |
| 01/16/2002 | CN1331128A Polypeptide-human ankyrin 12 and polynucleotide for coding it |
| 01/16/2002 | CN1331127A Polypeptide-human transport protein 35 and polynucleotide for coding it |
| 01/16/2002 | CN1331126A Polypeptide-human transport protein 43 and polynucleotide for coding it |
| 01/16/2002 | CN1331124A Polypeptide-human protein 15 containing repetitive tetrapolypeptide sequence and polynucleotide for coding it |
| 01/16/2002 | CN1331123A Polypeptide-human metabolic 3-type Glu receptor (mGLuR3) 9.9 and polynucleotide for coding it |
| 01/16/2002 | CN1331122A Polypeptide-human X2 theca repressor 10.23 and polynucleotide for coding it |
| 01/16/2002 | CN1331121A Polypeptide-human parkinson's syndrome associated protein 17 and polynucleotide for coding it |
| 01/16/2002 | CN1331120A Polypeptide-human sigma jreceptor 15.07 and polynucleotide for coding it |
| 01/16/2002 | CN1331118A Polypeptide-human purine receptor 16.5 and polynucleotide for coding it |
| 01/16/2002 | CN1331116A Polypeptide-accessory factor TIP30-32.12 for Mutual action of regulator proteins HIV-1 Tat and polynucleotide for coding it |
| 01/16/2002 | CN1331115A Polypeptide-methylated-CpG bindin 9.24 and polynucleotide for coding it |
| 01/16/2002 | CN1331112A Polypeptide-copine I27.5 and polynucleotide for coding it |
| 01/16/2002 | CN1331110A Polypeptide-air bubble protein gvpA-gvpD-41 and polynucleotide for coding it |
| 01/16/2002 | CN1331109A Polypeptide-blood coagulation factor V12.32 and polynudeotide for coding it |
| 01/16/2002 | CN1331108A Polypeptide-elongation factor 1-alpha subunit 26.18 and polynucleotide for coding it |
| 01/16/2002 | CN1331107A Polypeptide-epimorphin 9.9 and polynucleotide for coding it |
| 01/16/2002 | CN1331106A Polypeptide-proline-enriched gamma-carboxyl glutamate-protein 194.05 and polynucleotide for coding it |
| 01/16/2002 | CN1331105A Polypeptide-SMRAD5 protein 9.68 and polynucleotide for coding it |
| 01/16/2002 | CN1331104A Polypeptide-skim-Bop protein 39 and polynucleotide for coding it |
| 01/16/2002 | CN1331103A Polypeptide-protein transport associated Sec 2210.45 and polynucleotide for coding it |
| 01/16/2002 | CN1331102A Polypeptide-ProT-alpha protein 12.1 and polynucleotide for coding it |
| 01/16/2002 | CN1331101A Polypeptide-SNARE associated Golgi G527 Protein 20.68, and polynucleotide for coding it |
| 01/16/2002 | CN1331100A Polypeptide-binding RanBP15.29 and polynucleotide for coding it |
| 01/16/2002 | CN1331099A Polypeptide-proteasome p40.5 subunit 13.86 and polynucleotide for coding it |
| 01/16/2002 | CN1331097A Polypeptide-ribosomal protein S1923.1 and polynucleotide for coding it |
| 01/16/2002 | CN1331095A Polypeptide-bindin RanBP 11 and polynucleotide for coding it |
| 01/16/2002 | CN1331094A Polypeptide-kruppel-type zinc finger protein ZK23.65 and polynucleotide for coding it |
| 01/16/2002 | CN1331093A Polypeptide-MHC I-type CD8-alpha 11.55 and polynucleotide for coding it |
| 01/16/2002 | CN1331091A Polypeptide-mitochondrial sarcosine kinase subunit 22.11 and polynucleotide for coding it |
| 01/16/2002 | CN1331090A Polypeptide-signal peptiase 9.02 and polynucleotide for coding it |
| 01/16/2002 | CN1331089A Polypeptide-CAK1 antigen 9.02 and polynucleotide for coding it |
| 01/16/2002 | CN1331088A Polypeptide-CAK1 antigen 10.34 and polynucleotide for coding it |
| 01/16/2002 | CN1331087A Polypeptide-kringle protein 21 and polynucleotide for coding it |
| 01/16/2002 | CN1331085A Polypeptide-air bubble protein 34 and polynucleotide for coding it |
| 01/16/2002 | CN1331084A Polypeptide-signal recognition particle protein 33 and polynucleotide for coding it |
| 01/15/2002 | US6339147 Attachment of oligonucleotides to solid supports through Schiff base type linkages for capture and detection of nucleic acids |
| 01/15/2002 | US6339073 Uses of nicotinamide adenine dinucleotide and its derivatives for treatment of malignant and infectious diseases |
| 01/15/2002 | US6339066 Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate βI, βII, γ, δ, Ε, ζ and η isoforms of human protein kinase C |
| 01/15/2002 | US6339065 Episomal expression vector for human gene therapy |
| 01/15/2002 | US6338943 Methods for labeling nucleotides, labeled nucleotides and useful intermediates |
| 01/10/2002 | WO2002002627A2 Interferon-like protein zcyto21 |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002585A2 Low fluorescence nylon/glass composites for microdiagnostics |
| 01/10/2002 | WO2002002584A1 Base analogues |
| 01/10/2002 | WO2002002227A2 Devices and methods for carrying out chemical reactions using photogenerated reagents |
| 01/10/2002 | WO2002002172A1 Dna palindrome - oligoguanylic acid compositions and uses thereof |
| 01/10/2002 | WO2001045495A3 Potassium channel stress-related proteins and methods of use in plants |
| 01/10/2002 | US20020004593 Methods of making modified nucleosides |
| 01/10/2002 | US20020004591 Novel human proteases and polynucleotides encoding the same |
| 01/10/2002 | US20020004482 Treatment of acute lung injury and fibrosis with antagonists of avbeta6 |
| 01/10/2002 | US20020004230 Broth for biosynthesis of deoxyribonucleic acids |
| 01/10/2002 | US20020004227 Nucleotide sequences coding immunoglobulins; for use in treating cancer |
| 01/10/2002 | US20020004211 Methods for isolating and characterizing endogenous mRNA-protein (mRNP) complexes |
| 01/10/2002 | CA2415258A1 Devices and methods for carrying out chemical reactions using photogenerated reagents |
| 01/10/2002 | CA2412292A1 Base analogues |
| 01/10/2002 | CA2406649A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/09/2002 | EP1170368A2 Immunization by inoculation of dna transcription unit |
| 01/09/2002 | EP1169343A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 01/09/2002 | EP1169330A2 Information-carrying and information-processing polymers |
| 01/09/2002 | EP1169329A1 Oligonucleotides having alkylphosphonate linkages and methods for their preparation |
| 01/09/2002 | EP1169046A1 Pulmonary delivery of protonated/acidified nucleic acids |
| 01/09/2002 | EP1025113A4 Improved process for performing polynucleotide separations |
| 01/09/2002 | EP1017841A4 Chromatographic method for mutation detection using mutation site specifically acting enzymes |
| 01/09/2002 | EP1009812A4 Transgenic plants with tocopherol methyltransferase |
| 01/09/2002 | EP0716714B1 Oligonucleotides and methods for the detection of Chlamydia trachomatis |
| 01/09/2002 | CN1330717A Transformation system in field of flamentrous fungel hosts in chrysosporium |
| 01/09/2002 | CN1330079A Polypeptide-RNA polymerase II associated protein 9.57 and polynucleotide for encoding it |
| 01/09/2002 | CN1330078A Polypeptide-negative regulatory factor 9.02 of protein activating GTP enzyme and polynucleotide for coding it |
| 01/08/2002 | US6337393 Reducing liquid evaporation during solid phase micro-scale synthesis on an open environment solid support surface; the liquid reagent is a solvent with a high boiling point to prevent evaporation while maintaining a high reaction yield |
| 01/08/2002 | US6337209 Molecular constructs containing a carcinoembryonic antigen regulatory sequence |
| 01/08/2002 | US6337182 Method for the quantitative determination of DNA sequences |
| 01/08/2002 | US6337179 Methods and kits for detecting antibodies against an HIV variant |
| 01/08/2002 | CA2165821C Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection |
| 01/03/2002 | WO2002000877A2 Antisense oligonucleotides to inhibit angiogenesis and/or metastasis |
| 01/03/2002 | WO2002000842A2 Methods for isolating centromere dna |
| 01/03/2002 | WO2002000711A2 Ev-vegf nucleic acids and polypeptides and methods of use |
| 01/03/2002 | WO2002000677A1 Nucleic acids, proteins, and antibodies |
| 01/03/2002 | WO2002000618A2 Progesterone receptor-regulated gene expression and methods related thereto |
| 01/03/2002 | WO2001073125A3 High throughput screening array containing porous material |
| 01/03/2002 | WO2001071732A3 Porous ferro- or ferrimagnetic glass particles for isolating molecules |
| 01/03/2002 | WO2001046383A3 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 01/03/2002 | WO2001045494A3 Pyrophosphatase stress-related proteins and methods of use in plants |
| 01/03/2002 | US20020001844 Method for label-free detection of hybridized DNA targets |
| 01/03/2002 | US20020001839 Device for use in hybridization and binding analysis; for use in drug screening and sequencing nucleic acids; for use as tool in genetic analysis |
| 01/03/2002 | US20020001808 Methods employing oligonucleotide-binding e-tag probes |
| 01/03/2002 | US20020001612 Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| 01/03/2002 | DE10030588A1 Synthesizing carrier bound arrays of oligomers, useful for performing parallel polymerase chain reactions, e.g. for gene expression analysis, includes reversal of orientation |
| 01/03/2002 | CA2412612A1 Eg-vegf nucleic acids and polypeptides and methods of use |
| 01/02/2002 | EP1167379A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167378A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167377A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1165815A1 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus |
| 01/02/2002 | EP1165798A2 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |
| 01/02/2002 | EP1165763A1 Hydantoinase variants with improved properties and their use for the production of amino acids |
| 01/02/2002 | EP1165694A1 4,7-dichlororhodamine dyes useful as molecular probes |
| 01/02/2002 | EP1165597A1 Bifunctional molecules for delivery of therapeutics |